ARCHIVES

Study Identifies Risk Factors To Predict Contralateral Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 2 | February 27, 2009

Download PDF Visit The Full Archive

Related Articles

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

NCI to Spend 40 Percent of Stimulus Funds On Contracts

June 26, 2009

Panel Tells Carter Cancer Program Needs More Money

March 4, 1977

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

UPCI wins NCI SPORE grant for head and neck cancer.

September 24, 2004